ARCHIVES

New Compounds To Treat Gleevec-Resistant CML

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

June 3, 1988

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

Statins May Not Have Impact On Testosterone In The Blood

August 31, 2007

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

February 14, 2014

Voluntary Organizations: ACS Board Approves Prostate Cancer Funding Set-Asides

November 15, 1996